Home› Library› Protocol› Nad

ProtocolNadMay 18, 2026

NAD+ reconstitution protocol

Reconstitution of NAD+ (nicotinamide adenine dinucleotide) lyophilized vials. Notes on the cofactor's sensitivity to pH, light, and oxidation.

RECONSTITUTION & RESEARCH PROTOCOLS

Emerging clinical evidence

Research protocol intensities, summarized from published literature. The math is computed for the vial size you pick. Not a dosing recommendation.

Most direct-NAD+ clinical evidence is IV infusion at higher doses (Grant et al., 2019). SC research protocols are sparse — practitioner literature dominates. Oral NR/NMN precursor research (Martens et al., Yoshino et al.) uses different compounds and is not directly applicable to direct NAD+ SC dosing.

RESEARCH MODE
Final concentration
—

Reference research protocols from published peer-reviewed studies. Each card cites its source. This calculator is not a dosing recommendation. For research use only. Selection of any specific protocol is the responsibility of the qualified investigator under appropriate institutional oversight.

This protocol describes the reconstitution and storage of lyophilized NAD+ (nicotinamide adenine dinucleotide) in standard research workflows. NAD+ is a cellular cofactor, not a peptide — its physical and chemical handling differs in several important ways from peptide reconstitution. Values below are derived from published handling literature; experimental design parameters are the responsibility of the qualified investigator.

At a glance

Parameter Value
Recommended diluent Bacteriostatic Water (USP, 0.9% benzyl alcohol)
Recommended volume (500 mg vial) 5.0 mL
Final concentration 100 mg/mL
Stability — lyophilized ≥24 months at -20 °C, sealed, light-protected
Stability — reconstituted 14 days at 2–8 °C, light-protected (shorter than typical peptides)
pH sensitivity Most stable at pH 7.0–7.5. Avoid acidic conditions which accelerate hydrolysis.
Light sensitivity High. Always store light-protected and minimize exposure during handling.

Procedure

  1. Equilibrate. Allow vial to reach room temperature before reconstitution.
  2. Sterile prep. Wipe stopper with isopropyl. Use sterile syringe and needle.
  3. Inject diluent. Direct the stream along the inner glass wall. The lyophilized cake of NAD+ is bulkier than most peptides — be patient and let it dissolve completely.
  4. Dissolve gently. Swirl in a slow rotational motion. Do not shake. Full dissolution may take 2–3 minutes — longer than peptide reconstitution.
  5. Verify. Solution should be clear and very slightly pale yellow — this color is normal for concentrated NAD+. Cloudiness or strong yellow/orange indicates oxidation or degradation; do not use.

Compound notes

NAD+ is significantly more chemically labile than peptide compounds. The β-glycosidic bond is hydrolyzed slowly under acidic conditions and rapidly under alkaline conditions; the molecule also undergoes oxidation in the presence of light and dissolved oxygen. Three practical implications:

  • Shorter reconstituted shelf life. Plan on 14 days at 2–8 °C, not 30. After two weeks, oxidative breakdown products accumulate even with light protection.
  • Aliquot if you need more than a few weeks' supply. Frozen aliquots at -80 °C extend usable life to many months; -20 is acceptable for shorter intervals.
  • Light protection is non-optional. Use amber tubes for aliquoting, or wrap vials in foil. Direct light degrades NAD+ measurably within hours.

Storage

Reconstituted NAD+ is stable for approximately 14 days at 2–8 °C, light-protected. Aliquot for longer storage; frozen at -80 °C, aliquots remain usable for many months. Lyophilized vials store for ≥24 months at -20 °C light-protected.

Notes

This protocol describes reconstitution parameters used in published handling literature for NAD+ in research workflows. It is not a recommendation for any particular study design. For research use only. Not for human consumption.

References

  1. Yoshino J, Baur JA, Imai SI. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab 2018;27:513–528. PMID: 29249689
  2. Anderson KA, Madsen AS, Olsen CA, Hirschey MD. Metabolic control by sirtuins and other enzymes that sense NAD+, NADH, or their ratio. Biochim Biophys Acta Bioenerg 2017;1858:991–998. PMID: 28947253
NAD+ 500mg — Research Compound

NAD+ 500mg — Research Compound

99.649% HPLC ·Independently tested · COA provided

$100.00

Was this helpful?

Tell us what we got wrong or what would have helped — optional. We read every reply.

Thanks — we got it.
Have a question we didn't answer?
We reply to every research inquiry.
Email Merit →